In contrast, IL-10 has well-described anti-atherogenic properties (32) and is often associated with regulatory T cells, which can suppress activation and proliferation of immune cells during atherosclerosis, including IFNγ-producing CD4+ T cells (33). This evidence concerns the gene IFNG and atherosclerosis.